Stay updated with breaking news from Senseonics Eversense. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has approved extending the use of an implantable continuous glucose monitoring sensor for up to 6 months for adults with diabetes, according to a company press release. Senseonics’s Eversense E3 continuous glucose monitoring system is a fully implantable third-generation sensor that connects to a removable smart transmitter and mobile app displaying glucose values, trends and
Why Senseonics Is An Intriguing Speculative Buy At These Levels InvestorPlace 1 hr ago © Source: Shutterstock an image of a microscope There’s a place in most portfolios for small speculative positions. In this regard, I think investors may want to consider Senseonics Holdings (NYSEAMERICAN: © Provided by InvestorPlace an image of a microscope Senseonics is a medical technology company focused on providing implantable glucose monitoring (CGM) systems for those with diabetes. The company’s made some impressive progress on its commercialization of these devices, and appears ready...